Strong understanding of the Canadian healthcare system and reimbursement landscape
Experience with Health Technology Assessment (HTA) submissions to organizations such as INESSS and CADTH
Ability to synthesize clinical and economic data to support value propositions
Excellent communication and interpersonal skills, with the ability to influence stakeholders
Project management skills and the ability to work effectively in a cross-functional team
Experience with PCPA (Patented Medicine Prices Review Board) negotiations
Responsibilities
Develops and executes market access strategies and evidence generation plans to meet HTA requirements aligned with country objectives
Works cross-functionally with global, N.A and local medical and commercial functions to develop value propositions and messages tailored to multiple stakeholders including payers, clinicians, PAGs and policy makers
Project lead (including day to day management) for national HTA submissions, HC system implications and payer tools working closely with field Max to ensure optimal patient access to new and existing Biogen products
Supports the development and evaluation of innovative pricing strategies (including submissions) for PCPA and private payer negotiations
Develops and deploys market access solutions and tools to field teams (including training and support for payer meetings) to facilitate payer discussions
Fosters key relationships with payers and HTA bodies, developing innovative solutions which are win-wins for patients, the broader healthcare system and Biogen
Anticipates and shapes future dynamics in the external environment impacting market access and reimbursement, working closely with local and N.A teams to conve